| Literature DB >> 32661121 |
Xuyao Jiao1, Sarah Smith2, Gabrielle Stack1, Qi Liang2, Allan Bradley2, Paul Kellam2, Jorge E Galán3.
Abstract
Typhoid toxin is a virulence factor of Salmonella enterica serovar Typhi, the causative agent of typhoid fever, and is thought to be responsible for the symptoms of severe disease. This toxin has a unique A2B5 architecture with two active subunits, the ADP ribosyl transferase PltA and the DNase CdtB, linked to a pentameric B subunit, which is alternatively made of PltB or PltC. Here, we describe the generation and characterization of typhoid toxin-neutralizing human monoclonal antibodies by immunizing genetically engineered mice that have a full set of human immunoglobulin variable region genes. We identified several monoclonal antibodies with strong in vitro and in vivo toxin-neutralizing activity and different mechanisms of toxin neutralization. These antibodies could serve as the basis for the development of novel therapeutic strategies against typhoid fever.Entities:
Keywords: Salmonella Paratyphi; Salmonella Typhi; bacterial pathogenesis; bacterial toxins; infectious diseases; monoclonal antibodies; therapeutics; typhoid fever
Mesh:
Substances:
Year: 2020 PMID: 32661121 PMCID: PMC7504945 DOI: 10.1128/IAI.00292-20
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441